Wang Bing

Prof. Wang Bing

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2015 in Acta Biomaterialia
Verified
Journal Article
Closed access
TWTianyi Wang
Tianyi Wang
HJHaitao Jiang
Haitao Jiang
LWLong Wan
Long Wan
QZQinfu Zhao
Qinfu Zhao
TJTongying Jiang
Tongying Jiang
SWSiling Wang
Siling Wang

8 December 2015 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
YHYue Hou
Yue Hou
GXGuanbo Xie
Guanbo Xie
XLXia Liu
Xia Liu
GLGuoxun Li
Guoxun Li
CJCongcong Jia
Congcong Jia
WBWang Bing
Wang Bing

18 August 2022 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
TWTao Wang
Tao Wang
XBXinlei Ba
Xinlei Ba
XZXiaonan Zhang
Xiaonan Zhang
NZNa Zhang
Na Zhang
GWGuowen Wang
Guowen Wang
WBWang Bing
Wang Bing
Distant metastasis is the primary cause of breast cancer-associated death. The existing information, such as the precise molecular mechanisms and effective therapeutic strategies targeting metastasis, is insufficient to combat breast cancer. This study demonstrates that the protein tyrosine phosphatase PTPN18 is downregulated in metastatic breast cancer tissues and is associated with better metastasis-free survival. Ectopic expression of PTPN18 inhibits breast cancer cell metastasis. PTPN18 is translocated from the cytoplasm to the nucleus by MVP and importin β2 in breast cancer. Then, nuclear PTPN18 dephosphorylates ETS1 and promotes its degradation. Moreover, nuclear PTPN18 but not cytoplasmic PTPN18 suppresses transforming growth factor-β signaling and epithelial-to-mesenchymal transition by targeting ETS1. Our data highlight PTPN18 as a suppressor of breast cancer metastasis and provide an effective antimetastatic therapeutic strategy.

17 January 2019 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
JCJing Chen
Jing Chen
HGHaotian Guo
Haotian Guo
HJHaitao Jiang
Haitao Jiang
MNMwichie Namusamba
Mwichie Namusamba
CWChangli Wang
Changli Wang
WBWang Bing
Wang Bing

24 June 2021 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
YHYongye Huang
Yongye Huang
ZZZiyan Zhou
Ziyan Zhou
JZJin Zhang
Jin Zhang
ZHZhenzhen Hao
Zhenzhen Hao
YHYunhao He
Yunhao He
WBWang Bing
Wang Bing
In recent years, the repurposing of conventional and chemotherapeutic drugs is recognized as an alternative strategy for health care. The main purpose of this study is to strengthen the application of non‐oncological drug metformin on breast cancer treatment in the perspective of epigenetics. In the present study, metformin was found to inhibit cell proliferation, promote apoptosis and induce cell cycle arrest in breast cancer cells at a dose‐dependent manner. In addition, metformin treatment elevated acH3K9 abundance and decreased acH3K18 level. The expression of lncRNA MALAT1, HOTAIR, DICER1‐AS1, LINC01121 and TUG1 was up‐regulated by metformin treatment. In metformin‐treated cells, MALAT1 knock‐down increased the Bax/Bcl2 ratio and enhanced p21 but decreased cyclin B1 expression. The expression of Beclin1, VDAC1, LC3‐II, CHOP and Bip was promoted in the cells received combinatorial treatment of metformin and MALAT1 knock‐down. The reduced phosphorylation of c‐Myc was further decreased in the metformin‐treated cells in combination with MALAT1 knock‐down than metformin treatment alone. Taken together, these results provide a promising repurposed strategy for metformin on cancer treatment by modulating epigenetic modifiers.

23 March 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
KNKunwei Niu
Kunwei Niu
JXJialin Xu
Jialin Xu
YCYuhua Cao
Yuhua Cao
YHYue Hou
Yue Hou
MSMu Shan
Mu Shan
WBWang Bing
Wang Bing
BAP31 is a ubiquitously expressed endoplasmic reticulum (ER) membrane protein. The functions of BAP31 in the immune system have not been investigated due to the lack of animal models. Therefore we created a BAP31 conditional knockdown mouse by performing a knockdown of BAP31 in the thymus. In doing so, we demonstrate that the maturation of T cells is normal but the number of T cells is less in the thymus of the knockout mouse. In addition, the spleen and lymph nodes of peripheral immune organs contained a lesser proportion of the mature T cells in the thymus specific BAP31 knockout mice. The BAP31 knockout T cells decreased the proliferation activated by TCR signal pathways. Further studies clarified that BAP31 affects the phosphorylation levels of both Zap70/Lck/Lat of the upstream members and Akt/GSK/Jnk/Erk of the downstream members of TCR signal pathways. Furthermore, BAP31 can regulate the expression of some markers such as CD3/TCRα/TCRβ and some cytokines like IL-2/IFN-γ/IL-6/TNF-α which are important for T cell activation. Taken together, these results demonstrate that BAP31 may play an important role in T cell activation by regulating TCR signaling.